안허혈 증후군을 동반한 급성 망막중심동맥폐쇄의 치료 1예

• 영문명: Treatment of Acute Central Retinal Artery Occlusion with Ocular Ischemic Syndrome
• 발행기관: 대한안과학회
• 저자명: 이종환 문호석 남동흔 이대영,Jong Hwan Lee, MD, Ho Seok Moon, MD, Dong Heun Nam, MD, PhD, Dae Yeong Lee, MD
• 간행물 정보: 『대한안과학회지』Ophthalmological Society,volume55,number8, 1242~1247쪽, 전체 6쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2014.08.15

영문 초록

Purpose: We report a case of treatment of acute central retinal artery occlusion (CRAO) with ocular ischemic syndrome (OIS). Case summary: A 72-year-old man presented with acute loss of vision in the right eye on that day. At initial examination, visual acuity tested positive for light sensitivity in the right eye. Fundus examination demonstrated a visible embolus at the central retinal artery overlying the optic disc head and a cherry-red spot in the fovea. Fluorescein angiography revealed that filling of the choroidal circulation was delayed, and the arteriovenous transit time was even further delayed. Carotid angiography showed marked stenosis within the right internal carotid artery. Laboratory tests included blood tests for hypercoagulability evaluation, for which the results were non-specific. To treat acute CRAO with OIS in the right eye, transluminal Nd:YAG laser embolectomy (TYE) was performed twice, and carotid angioplasty with stenting was conducted within the stenosed internal carotid artery. One month after the TYE procedure and carotid stenting, the patient’s visual acuity improved to 0.06 and the arteriovenous transit time was within normal limits on fluorescein angiography. Conclusions: The visual prognosis in eyes with CRAO plus an associated choroidal circulatory disturbance is extremely poor. However, we experienced and reported a case of CRAO with OIS treated successfully through a prompt TYE procedure and carotid angioplasty with stenting. J Korean Ophthalmol Soc 2014;55(8):1242-1247

키워드

Carotid angioplasty with stenting, Central retinal artery occlusion, Ocular ischemic syndrome, Transluminal Nd:YAG laser embolectomy (TYE)